Celebrex Label Update Has CV Profile Similar To NSAIDs, No New GI Safety

The updated labeling for Pharmacia/Pfizer's COX-2 inhibitor Celebrex draws an unequivocal distinction between it and Merck's COX-2 Vioxx

More from Archive

More from Pink Sheet